BIOSPECIFICS TECHNOLOGIES CORP (29) | License Agreements (1)

Recent Contracts

Second Amendment to Second Amended and Restated Development License Agreement, dated February 26, 2019, by and between the Company and Endo Global Ventures (Filed With SEC on February 28, 2019)